IQAIF (Imaging Biometrics) OCF Margin %: 36.62% (As of Dec. 2025)


What is Imaging Biometrics OCF Margin %?

Imaging Biometrics IQAIF OCF Margin % is 36.62% as of Dec. 2025. The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Imaging Biometrics ranks better than 53.14% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Imaging Biometrics's Cash Flow from Operations for the six months ended in Dec. 2025 was $0.19 Mil. Imaging Biometrics's Revenue for the six months ended in Dec. 2025 was $0.53 Mil. Therefore, Imaging Biometrics's OCF Margin % for the quarter that ended in Dec. 2025 was 36.62%.

As of today, Imaging Biometrics's current OCF Yield % is 4.34%.

The historical rank and industry rank for Imaging Biometrics's OCF Margin % or its related term are showing as below:

IQAIF' s OCF Margin % Range Over the Past 10 Years
Min: -414.55   Med: -62.72   Max: 9.39
Current: 9.32

During the past 13 years, the highest OCF Margin % of Imaging Biometrics was 9.39%. The lowest was -414.55%. And the median was -62.72%.

IQAIF's OCF Margin % is ranked better than
53.14% of 668 companies
in the Healthcare Providers & Services industry
Industry Median: 8.33 vs IQAIF: 9.32

Imaging Biometrics OCF Margin % Related Terms

Imaging Biometrics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Imaging Biometrics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imaging Biometrics OCF Margin % Chart

Imaging Biometrics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -55.41 -69.98 -15.95 -18.14 9.38

Imaging Biometrics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.89 -15.75 -21.96 -17.57 36.62

IQAIF vs VEEV, BTSG, TEM: OCF Margin % Comparison

For the Health Information Services subindustry, Imaging Biometrics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Imaging Biometrics OCF Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Imaging Biometrics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Imaging Biometrics's OCF Margin % falls into.


Imaging Biometrics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Imaging Biometrics's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=0.099/1.055
=9.38 %

Imaging Biometrics's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0.193/0.527
=36.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 36.62% mean?
Imaging Biometrics (IQAIF) has a OCF Margin % of 36.62% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Imaging Biometrics and its competitors. According to the industry distribution chart, Imaging Biometrics ranks #313 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 46.9%.
Is Imaging Biometrics' OCF Margin % too high?
Imaging Biometrics' current OCF Margin % is 36.62%. The Healthcare Providers & Services industry median OCF Margin % is 8.33. Imaging Biometrics' value of 36.62% is 339.6% above this industry median. Based on the distribution chart, Imaging Biometrics ranks #313 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint.
How does Imaging Biometrics' OCF Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Imaging Biometrics ranks #313 out of 668 companies for OCF Margin %. This puts Imaging Biometrics in the upper half of its industry. The industry median OCF Margin % is 8.33. Imaging Biometrics' value of 36.62% is 339.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.33, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Imaging Biometrics's current OCF Margin % of 36.62% is 339.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Imaging Biometrics and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Imaging Biometrics's current OCF Margin % is 36.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imaging Biometrics stock overvalued right now?
Imaging Biometrics (IQAIF) has a current OCF Margin % of 36.62%. The stock's GF Value™ is $0.03, compared to a current price of $0.02 — trading 33.3% below its estimated fair value. The current OCF Margin % is 36.62% and 339.6% above the Healthcare Providers & Services industry median of 8.33. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Imaging Biometrics (IQAIF), the current OCF Margin % is 36.62% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imaging Biometrics Business Description

Other Exchanges IBAI:UK
Address IFC 5, Channel Islands, Saint Helier, JEY, JE1 1ST
Imaging Biometrics Ltd formerly, IQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on technologies. Its geographical segment includes United Kingdom, Switzerland, European Union, and the United States of America and reportable segments are holding company expenses, medical software, Oral GaM and organ-on-a-chip. The company derives a majority of its revenue from the United States of America. It also supplies medical technology solutions and has a neuroimaging product portfolio.